Bisphosphonate (BP) Treatment and Renal Impairment (RI) in Women with Postmenopausal Osteoporosis (PMO) in UK

被引：0
|
作者：
Xue, Fei [1 ]
Wentworth, Charles [2 ]
Petraro, Paul [1 ]
机构：
[1] Amgen Inc, CfOR, Thousand Oaks, CA 91320 USA
[2] Analyt Consulting Solut Inc, Wakefield, RI USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
514
引用
收藏
页码：271 / 272
页数：2
相关论文
共 50 条
  • [41] SIGNIFICANCE OF BODY MASS INDEX FOR THE EFFECT OF BISPHOSPHONATE THERAPY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Milenkovic, S. B.
    Dimic, A. N.
    Aleksic, I. M.
    Dimic, N. A.
    Stojanovic, S.
    Stamenkovic, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 979 - 980
  • [42] Calcium supply in women with postmenopausal osteoporosis on bisphosphonate therapy in daily practice.
    Ringe, JD
    Möller, G
    Wick, BC
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S281 - S281
  • [43] ASSOCIATION OF TREATMENT COMPLIANCE WITH FRACTURE (FX)-RELATED HOSPITALISATIONS AND THEIR ASSOCIATED COSTS AMONG HUNGARIAN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)
    Lakatos, P.
    Rakonczai, P.
    Cina, Z.
    Nagy, B.
    Psachoulia, E.
    Intorcia, M.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S373 - S373
  • [44] DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN ≥75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)
    Papapoulos, Socrates
    Mcclung, Michael R.
    Franchimont, Nathalie
    Adachi, Jonathan D.
    Bone, Henry G.
    Benhamou, Claude-Laurent
    Farrerons, Jordi
    Gallagher, John Christopher
    Halse, Johan
    Lippuner, Kurt
    Man, Zulema
    Minisola, Salvatore
    Torring, Ove
    Daizadeh, Nadia
    Wang, Andrea
    Wagman, Rachel B.
    Boonen, Steven
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S45 - S46
  • [45] Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
    Min, Yong-Ki
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (01) : 19 - 26
  • [46] Risedronate for prevention and treatment of osteoporosis in postmenopausal women
    Recker, RR
    Barger-Lux, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 465 - 477
  • [47] Combination and sequential treatment in women with postmenopausal osteoporosis
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Yavropoulou, Maria P.
    Makras, Polyzois
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (04) : 477 - 490
  • [48] Cyclical alendronate treatment in postmenopausal women with osteoporosis
    Kösüs, A
    Çapar, M
    Kösüs, N
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) : 182 - 184
  • [49] Factors related with osteoporosis treatment in postmenopausal women
    Montagner Rossi, Lia Mara
    Copes, Rafaela Martinez
    Dal Osto, Leo Canterle
    Flores, Clovis
    Comim, Fabio Vasconcellos
    Premaor, Melissa Orlandin
    MEDICINE, 2018, 97 (28)
  • [50] Denosumab treatment in postmenopausal women with osteoporosis reply
    Bone, Henry G.
    Wagman, Rachel B.
    Pannacciulli, Nicola
    Papapoulos, Socrates
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (10): : 768 - 769
12345